SLGL — SOL-GEL TECHNOLOGIES Share News
0.000.00%
Last trade - 00:00- $227.38m
- $179.45m
- $19.39m
NASDAQ TRADE HALT HALT NEWS PENDING AT 09:39 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:25 AM
Brief: Sol Gel Technologies - H.C. Wainwright Cuts Target Price To $20 From $21
Brief: Sol Gel Technologies- Co & Galderma Announce Exclusive Licenses For Commercialization Of Epsolay And Twyneo In The United States
Brief: Sol-Gel Announces Pipeline Update And Future Development Plans
Sol Gel Technologies Ltd reports results for the quarter ended in March - Earnings Summary
Brief: Sol Gel Technologies Ltd Reports Q1 2021 Financial Results and Corporate Update
Sol-Gel Technologies: Drops after delay in FDA review of skin cream
Brief: Sol-Gel Technologies Provides Update On FDA Review Of Epsolay
Brief: Sol-Gel Technologies Announces FDA Acceptance For Filing Of New Drug Application For Twyneo For The Treatment Of Acne Vulgaris
Brief: Sol-Gel Technologies Reports Third Quarter 2020 Financial Results And Corporate Update
NASDAQ RESUMED AT 09:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Sol-Gel Technologies Announces FDA Acceptance For Filing Of New Drug Application For Epsolay
Brief: Sol Gel Technologies Collaboration Partner Filed First-To-File Paragraph IV Certification For Duobrii
Brief: Sol Gel Technologies Q2 Revenue $1.1 Million
Brief: Sol-Gel Technologies Partnered Generic Product Expected To Launch In The Second Quarter Of 2021
Brief: Sol-Gel Announces Agreements With Perrigo Company For Three New Generic Product Candidates
Brief: Sol-Gel Technologies Reports Q1 2020 Financial Results